Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

The active form of vitamin D transcriptionally represses the Smad7 signaling and activates ERK to inhibit the differentiation of a inflammatory T helper cell subset and suppress experimental autoimmune encephalomyelitis.
Mature oligodendrocytes actively increase in vivo cytoskeletal plasticity following CNS damage.
Effects of Brain-Derived IL-2 Deficiency and the Development of Autoimmunity on Spatial Learning and Fear Conditioning.
Melatonin controls experimental autoimmune encephalomyelitis by altering the T effector/regulatory balance.
[Immunotherapy and infectious issues in multiple sclerosis : Self-injectable and oral drugs for immunotherapy].
[Neuroimmunology: theoretical and clinical aspects].
Sporadic Porphyria Cutanea Tarda in a Patient with Multiple Sclerosis Treated with Interferon Beta 1-a Therapy: A Case Report.
Neuroimmune semaphorin 4A as a drug and drug target for asthma.
FTY720 inhibits tumor growth and enhances the tumor-suppressive effect of topotecan in neuroblastoma by interfering with the sphingolipid signaling pathway.
Brain atrophy: an in-vivo measure of disease activity in multiple sclerosis.
Isolated bilateral horizontal gaze palsy as first manifestation of multiple sclerosis.
Occurrence of adverse events in chronic intrathecal baclofen infusion: a one-year follow-up study of 158 adults.
Low sensitivity to glucocorticoid inhibition of in vitro Th17-related cytokine production in multiple sclerosis patients is related to elevated plasma lipopolysaccharide levels.
A Further TWEAK to Multiple Sclerosis Pathophysiology.
Combined therapy with methylprednisolone and ulinastatin in experimental autoimmune encephalomyelitis.
Sulforaphane ameliorates the development of experimental autoimmune encephalomyelitis by antagonizing oxidative stress and Th17-related inflammation in mice.
Mood and coping in clinically isolated syndrome and multiple sclerosis.
Meaningful improvement in walking performance after Botulinum Neurotoxin A (BoNT-A) in chronic spastic patients.
Intrathecal immune reset in multiple sclerosis: Exploring a new concept.
Spasticity in multiple sclerosis: Associations with impairments and overall quality of life.
Expression of Lymphatic Markers in the Adult Rat Spinal Cord.
Ncf1 polymorphism reveals oxidative regulation of autoimmune chronic inflammation.
2-Cyclopropylimino-3-Methyl-1,3-Thiazoline Hydrochloride Inhibits Microglial Activation by Suppression of Nuclear Factor-Kappa B and Mitogen-Activated Protein Kinase Signaling.
Microparticles in multiple sclerosis and clinically isolated syndrome: effect on endothelial barrier function.
Single Dose of Glycoengineered Anti-CD19 Antibody (MEDI551) Disrupts Experimental Autoimmune Encephalomyelitis by Inhibiting Pathogenic Adaptive Immune Responses in the Bone Marrow and Spinal Cord While Preserving Peripheral Regulatory Mechanisms.

Pages